Generic Name

Timolol

Brand Names
Betimol, Istalol, Timolol GFS, Timoptic, Timoptic-XE
FDA approval date: June 08, 1990
Classification: beta-Adrenergic Blocker
Form: Tablet, Solution

What is Betimol (Timolol)?

Betimol ® is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances

Related Clinical Trials

Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris: A Comparative Study With Intense Pulsed Light (IPL)

Summary: Post-inflammatory erythema (PIE) is a common sequela of acne vulgaris, characterized by persistent erythematous macules resulting from superficial vascular dilation. Current treatment options include energy-based devices such as intense pulsed light (IPL); however, these modalities may be costly and require specialized equipment. Timolol, a non-selective beta-adrenergic receptor blocker, has demon...

Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Summary: Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Summary: Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Brand Information